Biofrontera Inc. (NASDAQ:BFRI) Short Interest Down 22.7% in December

Biofrontera Inc. (NASDAQ:BFRI) was the target of a large decrease in short interest in December. As of December 15th, there was short interest totalling 530,600 shares, a decrease of 22.7% from the November 30th total of 686,600 shares. Approximately 8.5% of the shares of the company are short sold. Based on an average daily volume of 2,870,000 shares, the days-to-cover ratio is presently 0.2 days.

Biofrontera Stock Up 3.7 %

Shares of NASDAQ:BFRI traded up $0.04 during trading on Friday, hitting $1.11. The stock had a trading volume of 218,657 shares, compared to its average volume of 1,018,731. Biofrontera has a 12-month low of $0.61 and a 12-month high of $3.90. The stock has a market capitalization of $8.60 million, a price-to-earnings ratio of -0.49 and a beta of 0.38. The stock has a 50-day simple moving average of $0.96 and a two-hundred day simple moving average of $1.04.

Analyst Upgrades and Downgrades

Separately, Benchmark reiterated a “buy” rating and set a $7.00 price objective on shares of Biofrontera in a research note on Friday, November 15th.

Biofrontera Company Profile

Biofrontera Inc, a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.